01855nas a2200169   4500000000100000008004100001100001000042700001000052700001000062700001100072245007900083856007500162300001200237490000700249520141500256022001401671       2017                            d1 aJue M1 aYoo J1 aKim M1 aPark H00aThe Lateral Tarsal Strip for Paralytic Ectropion in Patients with Leprosy.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705356/pdf/ad-29-742.pdf  a742-7460 v293 a<p><strong>Background: </strong>In patients with leprosy, paralysis of the facial nerve results in the lower eyelid ectropion and lagophthalmos as a sequela even when the leprosy is cured. Paralytic ectropion causes many functional and cosmetic eye problems, leading to blindness if left untreated.</p>

<p><strong>Objective: </strong>The purpose of this retrospective study is to evaluate the efficacy of surgical correction of paralytic ectropion, the lateral tarsal strip, in patients with leprosy.</p>

<p><strong>Methods: </strong>Between 2010 and 2015, 40 Korean patients (44 eyelids) with paralytic ectropion who had visited Korean Hansen Welfare Association Hospital were treated with the lateral tarsal strip. Four-point patients' global assessment scale, local complications, and recurrence were assessed at the end of follow-up period. The average follow-up period was 12 months.</p>

<p><strong>Results: </strong>In the 44 eyelids, recurrence was observed in 5 cases (5/44, 11.4%). There were no serious postoperative complications except mild size discrepancy of both eyes. Most patients were satisfied with the results and mean satisfaction scale was 2.6/3.</p>

<p><strong>Conclusion: </strong>The lateral tarsal strip is a simple, safe, and effective treatment method for the dermatologic surgeon to correct paralytic ectropion of mild to moderate degree in patients with leprosy.</p>
  a1013-9087